[144] Innovative Eyewear Inc SEC Filing

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) filed a Form 144 to notify a proposed sale of securities. The filer plans to sell 3,730 common shares through Raymond James & Associates on 09/23/2025 on NASDAQ, with an aggregate market value reported as $8,410. The shares were acquired as an RSU grant on 08/19/2025; the filer shows 5,400 RSU shares acquired and payment noted as cash. The issuer reports 4,574,602 shares outstanding. A related sale in the past three months shows Oswald Gayle sold 1,670 shares on 08/19/2025 for gross proceeds of $3,317. Certain contact and issuer address details are not provided in the filing.

Positive

• Filing provides required Rule 144 details including acquisition date, broker, proposed sale date, and amounts, supporting regulatory transparency
• Prior sales disclosed (1,670 shares on 08/19/2025), which improves transaction traceability for investors and regulators

Negative

• Some issuer/contact fields are blank or not provided, reducing completeness of disclosure
• Proposed sale involves RSUs acquired on 08/19/2025 and sold shortly thereafter, which may raise questions though no inference about motive is stated in the filing
• Aggregate market value is small relative to company scale (reported $8,410) indicating limited market impact

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice disclosing a small insider sale of newly granted RSUs, consistent with compliance requirements.

The Form 144 documents a proposed sale of 3,730 common shares acquired as RSUs on 08/19/2025 and to be sold on 09/23/2025 via Raymond James. The filing supplies required transaction dates, amounts, broker and exchange details, and prior sales in the three-month lookback. From a compliance perspective the filing appears to include the core elements Rule 144 requires: acquisition date, nature of acquisition, broker name, number of shares, and proposed sale date. Some issuer contact fields appear blank or redacted, which is a minor completeness issue but does not negate the disclosure of the sale. Impact rating: 0 (neutral).

Securities Analyst

TL;DR: The sale size is immaterial relative to total shares outstanding; provides transparency on insider liquidity but no material impact on valuation.

The 3,730-share proposed sale represents a small fraction of the issuer's reported 4,574,602 shares outstanding. The aggregate market value reported ($8,410) indicates a low absolute dollar amount involved. The filing also notes a prior 1,670-share sale on 08/19/2025 for $3,317. These disclosures increase transparency around insider transactions but do not constitute material corporate news or show change to operations, capital structure, or control. Impact rating: 0 (neutral).

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	3730	8410.00	4574602	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	RSU Grant	Issuer			5400	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Oswald Gayle 3551 NW 88th Dr, Apt 102 Coral Springs FL 33065	Common	08/19/2025	1670	3317.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Innovative Eyewear Inc (LUCY) report on Form 144?

The company filed a Rule 144 notice reporting a proposed sale of 3,730 common shares to be executed via Raymond James on 09/23/2025 on NASDAQ.

When were the shares being sold acquired?

The shares were acquired as an RSU grant on 08/19/2025, with 5,400 RSU shares recorded as acquired and payment shown as cash.

How many shares does the issuer report outstanding?

The filing reports 4,574,602 shares outstanding for the issuer.

Were there any related sales in the prior three months?

Yes. Oswald Gayle sold 1,670 common shares on 08/19/2025 for gross proceeds of $3,317.

What broker is handling the proposed sale?

Raymond James & Associates (address: 880 Carillon Parkway, St. Petersburg, FL 33716) is listed as the broker.